
|Articles|April 1, 2022
AJMC® in the Press, April 1, 2022
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
A piece by
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
New York Experts Push for Coordinated Obesity Care Teams
3
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
4
FDA Clears First Single-Biomarker Blood Test for Alzheimer
5




